ProPhase Labs, Inc. — Director's Dealing 2023

Jun 22, 2023

SEC Form 4/A — Form 4/A

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2023-06-16

Reporting Person: Barr Jason Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-16	Option (right to buy)	$7.31	A	40000	Acquired	2030-06-15	Common Stock (40000)	Direct

Footnotes

F1: The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the "Option"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023.

F2: This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023.